Aptar: CHI partners with Aptar Pharma for commercialization of the Quattrii DPI platform

Aptar Pharma will commercialize and promote Cambridge Healthcare Innovations' Quattrii blister-based dry powder inhaler platform, the companies said. According to the announcement, the platform is tunable and can be used with carrier or API-only formulations. CHI's web site says that the Quattrii DPI can be filled with up to 150 mg of powder and is [...]